C 
0.64
+1.60%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in HKD, from our data supplier.
Revenue, before interest expense
HK$489.9m
FY2016FY2025
Net income
HK$151.2m
FY2016FY2025
Total assets
HK$5.53bn
FY2016FY2025
Shareholders' equity
HK$1.63bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | HK$489.9m | HK$269.7m | HK$172.3m | HK$510.2m | HK$895.4m | HK$1.02bn | HK$978.7m | HK$791.2m | HK$278.1m | HK$87.5m |
| Research and development | — | — | HK$3 | HK$1 | HK$0 | HK$0 | HK$0 | — | — | — |
| Operating income | HK$338.9m | HK$170.4m | −HK$318.6m | HK$167.6m | HK$588.9m | HK$915.9m | HK$773.3m | HK$653.9m | HK$178.3m | −HK$521.1m |
| Net income | HK$151.2m | HK$50.8m | −HK$572.3m | −HK$436.6m | HK$291.2m | HK$393.2m | HK$356.9m | HK$245.2m | HK$157.7m | −HK$1.04bn |
| Diluted earnings per share | 0.14 | 0.05 | -0.51 | -0.39 | 0.25 | 0.33 | 0.01 | 0.21 | 0.16 | -2.69 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | HK$5.53bn | HK$3.84bn | HK$4.56bn | HK$10.85bn | HK$14.54bn | HK$11.17bn | HK$11.64bn | HK$10.44bn | HK$5.31bn | HK$1.74bn |
| Cash and short-term investments | HK$3.49bn | HK$2.61bn | HK$3.93bn | HK$9.66bn | HK$12.23bn | HK$8.45bn | HK$8.37bn | HK$5.08bn | HK$2.78bn | HK$587.1m |
| Total liabilities | HK$3.90bn | HK$2.46bn | HK$3.31bn | HK$9.25bn | HK$11.78bn | HK$8.57bn | HK$9.42bn | HK$8.57bn | HK$4.03bn | HK$586.4m |
| Debt | HK$3.17bn | HK$2.01bn | HK$2.93bn | HK$8.76bn | HK$10.91bn | HK$7.93bn | HK$9.10bn | HK$7.97bn | HK$3.51bn | HK$398.0m |
| Shareholders' equity | HK$1.63bn | HK$1.39bn | HK$1.25bn | HK$1.60bn | HK$2.76bn | HK$2.60bn | HK$2.22bn | HK$1.88bn | HK$1.28bn | HK$1.15bn |
| Shares outstanding | 1,095m | 1,102m | 1,120m | 1,126m | 1,182m | 1,191m | 47,679m | 1,172m | 994m | 387m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | HK$327.4m | HK$214.8m | HK$228.2m | HK$79.1m | HK$190.6m | −HK$61.5m | HK$233.8m | HK$248.1m |
| Operating income | HK$242.1m | HK$154.2m | HK$182.7m | HK$33.0m | HK$148.6m | −HK$172.5m | HK$136.5m | HK$118.5m |
| Net income | HK$139.6m | HK$33.3m | HK$117.9m | −HK$28.9m | HK$79.7m | −HK$321.8m | −HK$250.5m | −HK$158.0m |
| Diluted earnings per share | 0.13 | 0.03 | 0.11 | -0.03 | 0.07 | -0.29 | -0.22 | -0.14 |
| Total assets | HK$5.79bn | HK$5.53bn | HK$4.95bn | HK$3.84bn | HK$3.94bn | HK$4.56bn | HK$7.67bn | HK$10.85bn |
| Cash and short-term investments | HK$3.96bn | HK$3.49bn | HK$3.24bn | HK$2.61bn | HK$307.4m | HK$3.96bn | HK$6.70bn | HK$9.66bn |
| Debt | HK$3.31bn | HK$3.17bn | HK$2.51bn | HK$2.01bn | HK$2.20bn | HK$2.93bn | HK$5.73bn | HK$8.79bn |
| Shareholders' equity | HK$1.77bn | HK$1.63bn | HK$1.56bn | HK$1.39bn | HK$1.39bn | HK$1.25bn | HK$1.48bn | HK$1.60bn |
Financial ratios
Data as of 31 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | 59.7% | 69.5% | -174.6% | 32.8% | 65.8% | 89.9% | — |
| Net margin | 30.9% | 18.8% | -332.1% | -85.6% | 32.5% | 38.6% | — |
| Return on equity | 9.3% | 3.7% | -45.7% | -27.3% | 10.6% | 15.1% | — |
| Return on assets | 2.7% | 1.3% | -12.6% | -4.0% | 2.0% | 3.5% | — |
| Revenue growth | 81.6% | 56.5% | -66.2% | -43.0% | -12.1% | 4.1% | — |
| Earnings growth | 197.7% | -108.9% | 31.1% | -250.0% | -26.0% | 10.2% | — |
| Current ratio | 1.56x | 2.41x | 1.36x | 1.17x | 1.23x | 1.30x | — |
| Debt to equity | 1.95x | 1.43x | 2.31x | 5.46x | 3.94x | 3.02x | — |
| Equity ratio | 29.5% | 36.1% | 27.5% | 14.7% | 19.0% | 23.3% | — |
| Interest coverage | 2.69x | 1.75x | -1.16x | 0.63x | 3.38x | 2.88x | — |
| R&D as a share of sales | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Buybacks as a share of market value | 0.6% | 1.6% | 0.5% | 4.8% | 0.8% | 97.5% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -1.3% | -13.6% | 24.0% |
| Operating income | 26.4% | -18.0% | — |
| Net income | — | -17.4% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 67.0% | 24.8% | 55.5% | 52.8% |
| Net margin | 26.6% | -55.9% | -3.6% | -41.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 2.1 | 4.8 | -0.3 | -2.5 | 8.1 | 6.8 | 332.8 | 27.1 | 58.2 | -1.3 |
| Price to sales | 0.7 | 0.9 | 0.9 | 2.1 | 2.6 | 2.6 | 121.3 | 8.4 | 33.0 | 15.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 6 Jul 2022.
| FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | |
|---|---|---|---|---|---|
| Paid in the year | 0.075 | 0.132 | 0.132 | 0.08 | 1.302 |
- 40-to-1 reverse split · 29 Dec 2021
- 5-for-4 split · 18 Aug 2014
- 10-to-1 reverse split · 2 Feb 2012
- 20-to-1 reverse split · 24 May 2005
- 50-to-1 reverse split · 31 Dec 2002
- 10-for-1 split · 6 Apr 2000
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.